|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mao L: Oral squamous cell carcinoma -
progresses from risk assessment to treatment. Chin J Dent Res.
15:83–88. 2012.PubMed/NCBI
|
|
6
|
Wolchok JD and Chan TA: Cancer: Antitumour
immunity gets a boost. Nature. 515:496–498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mahoney KM, Rennert PD and Freeman GJ:
Combination cancer immunotherapy and new immunomodulatory targets.
Nat Rev Drug Discov. 14:561–584. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baumann M, Krause M, Overgaard J, Debus J,
Bentzen SM, Daartz J, Richter C, Zips D and Bortfeld T: Radiation
oncology in the era of precision medicine. Nat Rev Cancer.
16:234–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martin NE and D'Amico AV: Progress and
controversies: Radiation therapy for prostate cancer. CA Cancer J
Clin. 64:389–407. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones RM, Sloane VM, Wu H, Luo L, Kumar A,
Kumar MV, Gewirtz AT and Neish AS: Flagellin administration
protects gut mucosal tissue from irradiation-induced apoptosis via
MKP-7 activity. Gut. 60:648–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jun S, Jung YS, Suh HN, Wang W, Kim MJ, Oh
YS, Lien EM, Shen X, Matsumoto Y, McCrea PD, et al: LIG4 mediates
Wnt signalling-induced radioresistance. Nat Commun. 7:109942016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Advani SJ, Camargo MF, Seguin L, Mielgo A,
Anand S, Hicks AM, Aguilera J, Franovic A, Weis SM and Cheresh DA:
Kinase-independent role for CRAF-driving tumour radioresistance via
CHK2. Nat Commun. 6:81542015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu HC, Yang YC, Chen YJ, Lin H, Ou YC,
Chien CC, Huang EY, Huang HY, Lan J, Chi HP, et al: Increased
expression of SKP2 is an independent predictor of locoregional
recurrence in cervical cancer via promoting DNA-damage response
after irradiation. Oncotarget. 7:44047–44061. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai M, Ma X, Li X, Wang X, Mei Q, Li X, Wu
Z and Han W: The accomplices of NF-κB lead to radioresistance. Curr
Protein Pept Sci. 16:279–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahmed KM, Zhang H and Park CC: NF-κB
regulates radioresistance mediated by β1-integrin in
three-dimensional culture of breast cancer cells. Cancer Res.
73:3737–3748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aggarwal BB and Sung B: NF-κB in cancer: A
matter of life and death. Cancer Discov. 1:469–471. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y,
Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al: ATM-mediated
stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1. Nat Cell Biol. 16:864–875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Yang H, Palmbos PL, Ney G, Detzler
TA, Coleman D, Leflein J, Davis M, Zhang M, Tang W, et al:
ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates
radioresistance in pancreatic cancer cells. Cancer Res.
74:1778–1788. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Kang M, Qin YT, Wei ZX, Xiao JJ
and Wang RS: Sp1 is over-expressed in nasopharyngeal cancer and is
a poor prognostic indicator for patients receiving radiotherapy.
Int J Clin Exp Pathol. 8:6936–6943. 2015.PubMed/NCBI
|
|
20
|
Kang M, Xiao J, Wang J, Zhou P, Wei T,
Zhao T and Wang R: MiR-24 enhances radiosensitivity in
nasopharyngeal carcinoma by targeting SP1. Cancer Med. 5:1163–1173.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Enomoto A, Fukasawa T, Takamatsu N, Ito M,
Morita A, Hosoi Y and Miyagawa K: The HSP90 inhibitor
17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity
by downregulating serine/threonine kinase 38 via Sp1 inhibition.
Eur J Cancer. 49:3547–3558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cawley S, Bekiranov S, Ng HH, Kapranov P,
Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J,
Williams AJ, et al: Unbiased mapping of transcription factor
binding sites along human chromosomes 21 and 22 points to
widespread regulation of noncoding RNAs. Cell. 116:499–509. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zannetti A, Del Vecchio S, Carriero MV,
Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP and Salvatore
M: Coordinate up-regulation of Sp1 DNA-binding activity and
urokinase receptor expression in breast carcinoma. Cancer Res.
60:1546–1551. 2000.PubMed/NCBI
|
|
24
|
Vizcaíno C, Mansilla S and Portugal J: Sp1
transcription factor: A long-standing target in cancer
chemotherapy. Pharmacol Ther. 152:111–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Wei D, Huang S, Peng Z, Le X, Wu
TT, Yao J, Ajani J and Xie K: Transcription factor Sp1 expression
is a significant predictor of survival in human gastric cancer.
Clin Cancer Res. 9:6371–6380. 2003.PubMed/NCBI
|
|
26
|
Kou XX, Hao T, Meng Z, Zhou YH and Gan YH:
Acetylated Sp1 inhibits PTEN expression through binding to PTEN
core promoter and recruitment of HDAC1 and promotes cancer cell
migration and invasion. Carcinogenesis. 34:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang HC, Chuang JY, Jeng WY, Liu CI, Wang
AH, Lu PJ, Chang WC and Hung JJ: Pin1-mediated Sp1 phosphorylation
by CDK1 increases Sp1 stability and decreases its DNA-binding
activity during mitosis. Nucleic Acids Res. 42:13573–13587. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gong L, Ji WK, Hu XH, Hu WF, Tang XC,
Huang ZX, Li L, Liu M, Xiang SH, Wu E, et al: Sumoylation
differentially regulates Sp1 to control cell differentiation. Proc
Natl Acad Sci USA. 111:5574–5579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee HJ, Ryu JM, Jung YH, Lee KH, Kim DI
and Han HJ: Glycerol-3-phosphate acyltransferase-1 upregulation by
O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse
embryonic stem cell apoptosis via mTOR activation. Cell Death Dis.
7:e21582016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang WC and Hung JJ: Functional role of
post-translational modifications of Sp1 in tumorigenesis. J Biomed
Sci. 19:942012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Steck PA, Pershouse MA, Jasser SA, Yung
WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T,
et al: Identification of a candidate tumour suppressor gene, MMAC1,
at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maehama T and Dixon JE: The tumor
suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem.
273:13375–13378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng Z and Gan YH: Activating PTEN by
COX-2 inhibitors antagonizes radiation-induced AKT activation
contributing to radiosensitization. Biochem Biophys Res Commun.
460:198–204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng L, Zhang Y, Liu Y, Zhou M, Lu Y,
Yuan L, Zhang C, Hong M, Wang S and Li X: MiR-106b induces cell
radioresistance via the PTEN/PI3K/AKT pathways and p21 in
colorectal cancer. J Transl Med. 13:2522015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bardia A, Keenan TE, Ebbert JO, Lazovich
D, Wang AH, Vierkant RA, Olson JE, Vachon CM, Limburg PJ, Anderson
KE, et al: Personalizing aspirin use for targeted breast cancer
chemoprevention in postmenopausal women. Mayo Clin Proc. 91:71–80.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nimptsch K, Zhang X, Cassidy A, Song M,
O'Reilly ÉJ, Lin JH, Pischon T, Rimm EB, Willett WC, Fuchs CS, et
al: Habitual intake of flavonoid subclasses and risk of colorectal
cancer in 2 large prospective cohorts. Am J Clin Nutr. 103:184–191.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He E, Pan F, Li G and Li J: Fractionated
ionizing radiation promotes epithelial-mesenchymal transition in
human esophageal cancer cells through PTEN deficiency-mediated Akt
activation. PLoS One. 10:e01261492015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lo YC, Chang YH, Wei BL, Huang YL and
Chiou WF: Betulinic acid stimulates the differentiation and
mineralization of osteoblastic MC3T3-E1 cells: Involvement of
BMP/Runx2 and beta-catenin signals. J Agric Food Chem.
58:6643–6649. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lingaraju MC, Pathak NN, Begum J,
Balaganur V, Bhat RA, Ram M, Kumar D, Kumar D and Tandan SK:
Betulinic acid negates oxidative lung injury in surgical sepsis
model. J Surg Res. 193:856–867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alakurtti S, Mäkelä T, Koskimies S and
Yli-Kauhaluoma J: Pharmacological properties of the ubiquitous
natural product betulin. Eur J Pharm Sci. 29:1–13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ehrhardt H, Fulda S, Führer M, Debatin KM
and Jeremias I: Betulinic acid-induced apoptosis in leukemia cells.
Leukemia. 18:1406–1412. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tan Y, Yu R and Pezzuto JM: Betulinic
acid-induced programmed cell death in human melanoma cells involves
mitogen-activated protein kinase activation. Clin Cancer Res.
9:2866–2875. 2003.PubMed/NCBI
|
|
44
|
Pisha E, Chai H, Lee IS, Chagwedera TE,
Farnsworth NR, Cordell GA, Beecher CW, Fong HH, Kinghorn AD, Brown
DM, et al: Discovery of betulinic acid as a selective inhibitor of
human melanoma that functions by induction of apoptosis. Nat Med.
1:1046–1051. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang DM, Xu HG, Wang L, Li YJ, Sun PH, Wu
XM, Wang GJ, Chen WM and Ye WC: Betulinic acid and its derivatives
as potential antitumor agents. Med Res Rev. 35:1127–1155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li L, Du Y, Kong X, Li Z, Jia Z, Cui J,
Gao J, Wang G and Xie K: Lamin B1 is a novel therapeutic target of
betulinic acid in pancreatic cancer. Clin Cancer Res. 19:4651–4661.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao Y, Jia Z, Kong X, Li Q, Chang DZ, Wei
D, Le X, Suyun H, Huang S, Wang L, et al: Combining betulinic acid
and mithramycin a effectively suppresses pancreatic cancer by
inhibiting proliferation, invasion, and angiogenesis. Cancer Res.
71:5182–5193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kasperczyk H, La Ferla-Brühl K, Westhoff
MA, Behrend L, Zwacka RM, Debatin KM and Fulda S: Betulinic acid as
new activator of NF-kappaB: Molecular mechanisms and implications
for cancer therapy. Oncogene. 24:6945–6956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zuco V, Supino R, Righetti SC, Cleris L,
Marchesi E, Gambacorti-Passerini C and Formelli F: Selective
cytotoxicity of betulinic acid on tumor cell lines, but not on
normal cells. Cancer Lett. 175:17–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bache M, Bernhardt S, Passin S, Wichmann
H, Hein A, Zschornak M, Kappler M, Taubert H, Paschke R and
Vordermark D: Betulinic acid derivatives NVX-207 and B10 for
treatment of glioblastoma - an in vitro study of cytotoxicity and
radiosensitization. Int J Mol Sci. 15:19777–19790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bache M, Zschornak MP, Passin S, Kessler
J, Wichmann H, Kappler M, Paschke R, Kaluđerović GN, Kommera H,
Taubert H, et al: Increased betulinic acid induced cytotoxicity and
radiosensitivity in glioma cells under hypoxic conditions. Radiat
Oncol. 6:1112011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bernier J: Current state-of-the-art for
concurrent chemoradiation. Semin Radiat Oncol. 19:3–10. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn
J and Song JY: An effective strategy for increasing the
radiosensitivity of Human lung Cancer cells by blocking
Nrf2-dependent antioxidant responses. Free Radic Biol Med.
53:807–816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Provencio M, Sánchez A, Garrido P and
Valcárcel F: New molecular targeted therapies integrated with
radiation therapy in lung cancer. Clin Lung Cancer. 11:91–97. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bussink J, van der Kogel AJ and Kaanders
JH: Activation of the PI3-K/AKT pathway and implications for
radioresistance mechanisms in head and neck cancer. Lancet Oncol.
9:288–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nishida Y, Mizutani N, Inoue M, Omori Y,
Tamiya-Koizumi K, Takagi A, Kojima T, Suzuki M, Nozawa Y, Minami Y,
et al: Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA
ligase IV transcription of daunorubicin-resistant leukemia cell
lines. Biochim Biophys Acta. 1839:265–274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang Y, Zheng L, Ding Y, Li Q, Wang R,
Liu T, Sun Q, Yang H, Peng S, Wang W, et al: MiR-20a induces cell
radioresistance by activating the PTEN/PI3K/Akt signaling pathway
in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu ZL, Wang H, Liu J and Wang ZX:
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and
chemo- or radioresistance in non-small cell lung cancer cells by
targeting PTEN. Mol Cell Biochem. 372:35–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Eder-Czembirek C, Erovic BM, Czembirek C,
Brunner M, Selzer E, Pötter R and Thurnher D: Betulinic acid a
radiosensitizer in head and neck squamous cell carcinoma cell
lines. Strahlenther Onkol. 186:143–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Stambolic V, MacPherson D, Sas D, Lin Y,
Snow B, Jang Y, Benchimol S and Mak TW: Regulation of PTEN
transcription by p53. Mol Cell. 8:317–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Virolle T, Adamson ED, Baron V, Birle D,
Mercola D, Mustelin T and de Belle I: The Egr-1 transcription
factor directly activates PTEN during irradiation-induced
signalling. Nat Cell Biol. 3:1124–1128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kim DH, Xiao Z, Kwon S, Sun X, Ryerson D,
Tkac D, Ma P, Wu SY, Chiang CM, Zhou E, et al: A dysregulated
acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.
EMBO J. 34:184–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hsu TI, Wang MC, Chen SY, Huang ST, Yeh
YM, Su WC, Chang WC and Hung JJ: Betulinic acid decreases
specificity protein 1 (Sp1) level via increasing the sumoylation of
sp1 to inhibit lung cancer growth. Mol Pharmacol. 82:1115–1128.
2012. View Article : Google Scholar : PubMed/NCBI
|
